TULSA and the External Sphincter: A Retrospective Analysis

TULSA and the External Sphincter: A Retrospective Analysis

At RSNA 2023 in Chicago, Dr. Busch presented on the retrospective analysis of MRI-guided transurethral ultrasound ablation (TULSA) in prostate cancer lesions at the extreme apex. The clinical findings show TULSA is a promising prostate cancer treatment with minimal impact on urinary continence for thermal ablation of extreme apical lesions. With a prostatectomy, the urologist is unable to see the difference between the apex of the prostate and...

read more
The Heart of Busch Center

The Heart of Busch Center

While Busch Center is rooted in over 40 years of experience with a passion for preserving quality of life for those diagnosed with prostate cancer or BPH, it’s also rooted in the hearts of our founders, Dr. Joe and Kathy Busch.  What started as a “typical” event inspired Dr. Busch and Kathy to shift their focus from cancer care to prostate cancer diagnosis and treatment. From utilizing PET Scan machines in 1998 to today’s MRI imaging, the...

read more
Fertility Preservation Services Now Available at Busch Center

Fertility Preservation Services Now Available at Busch Center

Busch Center is excited to offer a new service for men in search of safe, effective fertility protection. Our sperm analysis and up to 5-year cryostorage kits are available in-center for both TULSA treatment and non-TULSA patients. Collection of samples can be completed in the privacy of your own home and then you take the kit to your nearest UPS for delivery to the lab. Once the specimen has been received by the lab the viability of the sample...

read more
Cause for Concern: Does Your Blood Clot Point to Prostate Cancer?

Cause for Concern: Does Your Blood Clot Point to Prostate Cancer?

When my dad suffered a pulmonary embolism in October of 2021, we were in shock. At 64 years of age, Morris is a relatively healthy man with no prior issues. So – after returning home from a six-day stay in the hospital, we began our healing journey. We embarked on the search for what, exactly, caused this blood clot to form in my father’s leg, break off and travel to his lungs. By all counts, we were blessed he was alive. As I started...

read more
TULSA: Bringing Hope After Radiation Therapy

TULSA: Bringing Hope After Radiation Therapy

In the medical field, it’s unfortunately still common practice to recommend a prostatectomy directly following a prostate cancer diagnosis despite the growing knowledge of safer alternatives. Prostatectomy surgery involves removing the prostate which can lead to a host of other health risks including urinary incontinence, erectile dysfunction, narrowing of the urethra (making it difficult to pass urine), and last but not least a decrease in the...

read more
British Institute of Radiology Features Dr. Joseph Busch

British Institute of Radiology Features Dr. Joseph Busch

Prostate cancer continues to have a negative impact on the duration and quality of life for males and their families. MRI is transforming the pathway of prostate cancer detection, diagnosis, staging, and surveillance, backed by multiple Level 1 studies and robust reporting standards. This evolving paradigm of MRI-directed care is now being expanded to include in-bore MRI-guided prostate tissue ablation techniques, which reduce the burden of...

read more
Journal of Urology Features TULSA-PRO Research

Journal of Urology Features TULSA-PRO Research

One of the most widely-read and highly-cited journals in the field of urology recently featured the TULSA-PRO system used at Busch Center. A study analyzing the treatment of 115 men using TULSA-PRO graced the cover of the Journal of Urology, giving doctors across the nation a deeper look into this groundbreaking procedure.  The TULSA procedure uses magnetic resonance imaging (MRI) to guide doctors in delivering precise doses of ultrasound...

read more
Why TULSA is the Best Way to Treat BPH

Why TULSA is the Best Way to Treat BPH

Benign prostatic hyperplasia (BPH), also called prostate gland enlargement, is very common in older men. By age 60, over one-half of men have BPH; by age 85, the number climbs to 90%, according to the American Urological Association (AUA). An enlarged prostate gland can cause uncomfortable urinary symptoms, such as increased urges to urinate, especially at night. It can also cause bladder, urinary tract, or kidney problems. There are various...

read more

Medical Studies

Personalized Treatment for Patients with Prostate Cancer Using MRI-guided Transurethral Ultrasound Ablation (TULSA)

MAGNETOM Flash
TULSA is a new technology which has demonstrated promising early oncological results with a well-tolerated safety profile. As Prostate Cancer disease localization continues to improve, it is expected that targeted treatment will become increasingly part of localized Prostate Cancer management. As MRI is already embedded within TULSA, used both to guide, plan, and monitor treatment, TULSA is well-positioned to address the changing landscape of Prostate Cancer disease management.

Palliative MRI-guided Transurethral Ultrasound Ablation for Symptomatic Locally Advanced Prostate Cancer

Scandinavian Journal of Urology
The study concludes TULSA appears safe and feasible for palliative ablation of locally advanced prostate cancer. The therapy seems to accomplish long-term hematuria control, can relieve bladder outlet obstruction in selected patients, and seems to reduce the burden of hospitalization due to local complications.

MRI-Guided Transurethral Ultrasound Ablation for BPH

Journal of Endourology
This retrospective analysis demonstrates promising safety and feasibility of TULSA to relieve LUTS, with improvements in IPSS comparable to modern minimally invasive surgical therapies. Larger controlled studies with BPH-specific ablation plans in men seeking treatment for LUTS are warranted.

Patient Testimonials

Busch Center Experience

America’s Flawed Standard of Care

Importance of Early Detection

About Prostate MRI Screening

Treating Prostate Cancer

TULSA Procedure